Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marsden

Showing results (291-300 of 1,476) with videos related to

Pageof 148
Sort By:
Clinical Neuropharmacology|April 1, 1997
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesiasF Stocchi, G Nordera, C D Marsden
Expert Opinion on Drug Discovery|March 19, 2013
High-throughput structural characterisation of therapeutic protein targetsBrian D Marsden, Michael Sundstrom, Stefan Knapp
British Journal of Pharmacology|May 1, 1979
Evidence for metabolite involvement in bromocryptine-induced circling behaviour [proceedings]P Jenner, C D Marsden, C Reavill
Neurology|August 1, 1979
Cortical reflex myoclonusM Hallett, D Chadwick, C D Marsden
Life Sciences|August 7, 1978
An experimental model of tardive dyskinesiasA Clow, P Jenner, C D Marsden
Neuroscience Letters|October 24, 1994
GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatmentJ Jolkkonen, P Jenner, C D Marsden
British Journal of Pharmacology|November 1, 1978
Supersensitivity of cerebral dopamine receptors during on-going chronic (six months) administration of trifluoperazine to rats [proceedings]A Clow, P Jenner, C D Marsden
The Journal of Pharmacy and Pharmacology|October 1, 1982
Are dopamine receptors present on human lymphocytes?S Fleminger, P Jenner, C D Marsden
The Journal of Pharmacy and Pharmacology|August 1, 1993
Chronic administration does not alter the pharmacokinetic profile of L-dopa in the ratS Rose, P Jenner, C D Marsden
The American Journal of Tropical Medicine and Hygiene|April 1, 1992
Control of the transmission of Chagas' disease in Mambai, Goias, Brazil (1980-1988)M T Garcia-Zapata, P D Marsden
Pageof 148

Showing results (291-300 of 1,476) with videos related to

Sort By:
Pageof 148
Clinical Neuropharmacology|April 1, 1997
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesiasF Stocchi, G Nordera, C D Marsden
Expert Opinion on Drug Discovery|March 19, 2013
High-throughput structural characterisation of therapeutic protein targetsBrian D Marsden, Michael Sundstrom, Stefan Knapp
British Journal of Pharmacology|May 1, 1979
Evidence for metabolite involvement in bromocryptine-induced circling behaviour [proceedings]P Jenner, C D Marsden, C Reavill
Neurology|August 1, 1979
Cortical reflex myoclonusM Hallett, D Chadwick, C D Marsden
Life Sciences|August 7, 1978
An experimental model of tardive dyskinesiasA Clow, P Jenner, C D Marsden
Neuroscience Letters|October 24, 1994
GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatmentJ Jolkkonen, P Jenner, C D Marsden
British Journal of Pharmacology|November 1, 1978
Supersensitivity of cerebral dopamine receptors during on-going chronic (six months) administration of trifluoperazine to rats [proceedings]A Clow, P Jenner, C D Marsden
The Journal of Pharmacy and Pharmacology|October 1, 1982
Are dopamine receptors present on human lymphocytes?S Fleminger, P Jenner, C D Marsden
The Journal of Pharmacy and Pharmacology|August 1, 1993
Chronic administration does not alter the pharmacokinetic profile of L-dopa in the ratS Rose, P Jenner, C D Marsden
The American Journal of Tropical Medicine and Hygiene|April 1, 1992
Control of the transmission of Chagas' disease in Mambai, Goias, Brazil (1980-1988)M T Garcia-Zapata, P D Marsden
Pageof 148